Hologic, Inc (HOLX) concluded trading on Wednesday at a closing price of $68.75, with 3.95 million shares of worth about $271.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.38% during that period and on January 15, 2025 the price saw a loss of about -2.07%. Currently the company’s common shares owned by public are about 231.72M shares, out of which, 223.70M shares are available for trading.
Stock saw a price change of -5.42% in past 5 days and over the past one month there was a price change of -8.44%. Year-to-date (YTD), HOLX shares are showing a performance of -4.63% which decreased to -5.50% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $69.46 but also hit the highest price of $84.67 during that period. The average intraday trading volume for Hologic, Inc shares is 1.99 million. The stock is currently trading -4.41% below its 20-day simple moving average (SMA20), while that difference is down -9.27% for SMA50 and it goes to -11.21% lower than SMA200.
Hologic, Inc (NASDAQ: HOLX) currently have 231.72M outstanding shares and institutions hold larger chunk of about 103.81% of that.
The stock has a current market capitalization of $15.60B and its 3Y-monthly beta is at 0.98. PE ratio of stock for trailing 12 months is 20.70, while it has posted earnings per share of $3.32 in the same period. Its PEG reads 2.07 and has Quick Ratio of 3.03 while making debt-to-equity ratio of 0.52. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HOLX, volatility over the week remained 2.62% while standing at 2.14% over the month.
Analysts are in expectations that Hologic, Inc (HOLX) stock would likely to be making an EPS of 1.01 in the current quarter, while forecast for next quarter EPS is 1.04 and it is 4.72 for next year. For the current quarter EPS, analysts have given the company a lowest target 1.0 which is 1.02 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.98 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 4.36% while it is estimated to increase by 9.86% in next year.
Coverage by Needham stated Hologic, Inc (HOLX) stock as a Buy in their note to investors on December 10, 2024, suggesting a price target of $90 for the stock. On December 10, 2024, Jefferies Initiated their recommendations, while on October 01, 2024, Citigroup Downgrade their ratings for the stock with a price target of $85. Stock get an Overweight rating from Stephens on June 27, 2024.
